Acta Haematol
- PARIGGER T, Drothler S, Scherhaufl C, Gassner FJ, et al
Oncogenic MTOR signaling axis compensates BTK inhibition in a Chronic Lymphocytic
Leukemia patient with Richter Transformation: A Case Report and Review of the
Literature.
Acta Haematol. 2024 Feb 24. doi: 10.1159/000537791.
Am J Hematol
- MIRVIS E, Sairam S, Vainieri E, Tona F, et al
Pituitary apoplexy in acute promyelocytic leukemia.
Am J Hematol. 2024 Feb 29. doi: 10.1002/ajh.27277.
- JIANG M, Wang X, Yu M, Jiang S, et al
Report of IRF2BP1 as a novel partner of RARA in variant acute promyelocytic
leukemia.
Am J Hematol. 2024 Feb 27. doi: 10.1002/ajh.27272.
- SANDBERG Y, Budel LM, Bain BJ
Neutrophilic leukemoid reaction or chronic neutrophilic leukemia-not always so
simple.
Am J Hematol. 2024 Feb 23. doi: 10.1002/ajh.27268.
Ann Hematol
- PALANI HK, Ganesan S, Balasundaram N, Venkatraman A, et al
Cystatin F a potential diagnostic biomarker in acute promyelocytic leukemia.
Ann Hematol. 2024 Mar 1. doi: 10.1007/s00277-024-05673.
- SCHWANER I, Kuhn T, Losem C, Wolff T, et al
Low incidence of tumor lysis syndrome in elderly patients with chronic
lymphocytic leukemia treated with venetoclax under real-world conditions: results
from the prospective observational VeRVe study.
Ann Hematol. 2024 Feb 29. doi: 10.1007/s00277-024-05638.
- CHEN Y, Zheng J, Weng Y, Wu Z, et al
Myelodysplasia-related gene mutations are associated with favorable prognosis in
patients with TP53-mutant acute myeloid leukemia.
Ann Hematol. 2024 Feb 27. doi: 10.1007/s00277-024-05679.
Blood
- MURTADHA M, Park M, Zhu Y, Caserta E, et al
CD38-directed, single-chain T cell-engager targets leukemia stem cells through
IFNgamma-induced CD38 expression.
Blood. 2024 Feb 26:blood.2023021570. doi: 10.1182/blood.2023021570.
- VAN OUTERSTERP I, Tasian SK, Reichert CE, Boeree A, et al
Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: The
role of kinase type and SH3 domain.
Blood. 2024 Feb 23:blood.2023023120. doi: 10.1182/blood.2023023120.
- BISWAS J, Abdel-Wahab O
A new SAGA for AML: targeting SGF29 in AML.
Blood. 2024;143:657-658.
Cancer Chemother Pharmacol
- MARCELLETTI JF, Sikic BI
Continuous 72-h infusion of zosuquidar with chemotherapy in patients with newly
diagnosed acute myeloid leukemia stratified for leukemic blast P-glycoprotein
phenotype.
Cancer Chemother Pharmacol. 2024 Feb 26. doi: 10.1007/s00280-024-04656.
Cancer Res
- JIN P, Wang X, Jin Q, Zhang Y, et al
Mutant U2AF1-induced mis-splicing of mRNA translation genes confers resistance to
chemotherapy in acute myeloid leukemia.
Cancer Res. 2024 Feb 28. doi: 10.1158/0008-5472.CAN-23-2543.
Int J Hematol
- SHIOZAWA Y, Fujita S, Nannya Y, Ogawa S, et al
First report of familial mixed phenotype acute leukemia: shared clinical
characteristics, Philadelphia translocation, and germline variants.
Int J Hematol. 2024 Feb 29. doi: 10.1007/s12185-024-03724.
- CHOED-AMPHAI C, Khorana J, Sathitsamitphong L, Natesirinilkul R, et al
Predictive factors for L-asparaginase hypersensitivity in pediatric acute
lymphoblastic leukemia.
Int J Hematol. 2024 Feb 29. doi: 10.1007/s12185-024-03725.
J Pediatr Hematol Oncol
- HOSHINO Y, Moriya K, Mitsui-Sekinaka K, Hashimoto Y, et al
Noonan Syndrome-related Myeloproliferative Disorder Occurring in the Neonatal
Period: Case Report and Literature Review.
J Pediatr Hematol Oncol. 2024;46:e176-e179.
- WOLFSET N, Pashmineh Azar AR, Phillips CA, Stein M, et al
Coronavirus Disease 2019 mRNA Vaccination Appears Safe in Pediatric Patients With
Hypersensitivity to Polyethylene Glycolated Escherichia coli L-asparaginase.
J Pediatr Hematol Oncol. 2024;46:e202-e204.
- JIANG MR, Ahmet A, Lawrence S, Bassal M, et al
Hypoglycemia Associated With PEG-asparaginase and 6-MP Therapy During Treatment
of Acute Lymphoblastic Leukemia in Pediatric Patients: A Case Series.
J Pediatr Hematol Oncol. 2024;46:e121-e126.
Leuk Lymphoma
- NASKAR S, Paul T, Kulkarni JD, Anand KC, et al
TCF3::PBX1 fusion pediatric B acute lymphoblastic leukemia in disguise behind the
eyes - an unusual clinicopathologic presentation with hyperdiploid clone.
Leuk Lymphoma. 2024 Feb 26:1-5. doi: 10.1080/10428194.2024.2320827.
- STEIN EM, Fathi AT, Harb WA, Colak G, et al
Results from phase 1 of the MANIFEST clinical trial to evaluate the safety and
tolerability of pelabresib in patients with myeloid malignancies.
Leuk Lymphoma. 2024;65:503-510.
- PARVIZ M, Agius R, Rotbain EC, Vainer N, et al
Identifying CLL patients at high risk of atrial fibrillation on treatment using
machine learning.
Leuk Lymphoma. 2024;65:449-459.
- ALDOSS I, Clark MC, Wang X, Forman SJ, et al
Leveraging CD19CAR T cells early in the treatment of older patients with B-ALL:
are we there yet?
Leuk Lymphoma. 2024;65:440-448.
Leuk Res
- ELGHETANY MT, Patnaik MM, Khoury JD
Myelodysplastic neoplasms evolving from inherited bone marrow failure syndromes /
germline predisposition syndromes: Back under the microscope.
Leuk Res. 2024;137:107441.
- RAMOS-CILLAN S, Lainez-Gonzalez D, Solan L, Blas C, et al
When the devil is in the details: Similarities and differences between WHO and
ICC classifications of AML.
Leuk Res. 2024;137:107440.
Leukemia
- CLAUDIANI S, Chughtai F, Khan A, Hayden C, et al
Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for
chronic myeloid leukemia: managing intolerance and resistance.
Leukemia. 2024 Feb 29. doi: 10.1038/s41375-024-02187.
- YANG X, Liu J, Liu W, Wu H, et al
circFAM193B interaction with PRMT6 regulates AML leukemia stem cells
chemoresistance through altering the oxidative metabolism and lipid peroxidation.
Leukemia. 2024 Feb 29. doi: 10.1038/s41375-024-02189.
- FLYGT H, Soderlund S, Richter J, Saussele S, et al
Correction: Treatment-free remission after a second TKI discontinuation attempt
in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim
results from the DAstop2 trial.
Leukemia. 2024 Feb 28. doi: 10.1038/s41375-024-02184.
- MONTALBAN-BRAVO G, Rodriguez-Sevilla JJ, Swanson DM, Kanagal-Shamanna R, et al
Influence of co-mutational patterns in disease phenotype and clinical outcomes of
chronic myelomonocytic leukemia.
Leukemia. 2024 Feb 28. doi: 10.1038/s41375-024-02190.
- JUNK SV, Forster A, Schmidt G, Zimmermann M, et al
Germline variants in patients developing second malignant neoplasms after therapy
for pediatric acute lymphoblastic leukemia-a case-control study.
Leukemia. 2024 Feb 27. doi: 10.1038/s41375-024-02173.
Proc Natl Acad Sci U S A
- LI JF, Cheng WY, Lin XJ, Wen LJ, et al
Aging and comprehensive molecular profiling in acute myeloid leukemia.
Proc Natl Acad Sci U S A. 2024;121:e2319366121.
- ROSELLE C, Horikawa I, Chen L, Kelly AR, et al
Enhancing chimeric antigen receptor T cell therapy by modulating the p53
signaling network with Delta133p53alpha.
Proc Natl Acad Sci U S A. 2024;121:e2317735121.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016